INDEX 835
Gravolseedimenhydrinate
gray collie syndrome, 66
Great Dane, 738
acne, 157
acral lick dermatitis, 228
color dilution alopecia, 434
cryptococcosis, 522
epidermolysis bullosa acquisita, 64, 190
hypothyroidism, 417
idiopathic sterile granuloma, 589
pedal folliculitis and furunculosis, 214
great Pyrenees, 738
Grenz zone, 39
greyhound, 738
cutaneous adverse drug reactions, 273
cutaneous and renal glomerular vasculopathy, 63,
699
ivermectin sensitivity, 301, 637
pattern baldness, 60, 80
solar-induced dermatoses, 575, 616, 673
griseofulvin, 323–324, 779
Gris-PEGseegriseofulvin
growth hormone (GH)
for alopecia X, 341
responsive alopeciaseealopecia X
hair coat, descriptive terms, 11
hair follicle tumors, 673
clinical features, 676–677,689–691
diagnostics, 677, 678
differential diagnosis, 677
prognosis, 680
signalment/history, 674, 675
therapeutics, 678–679
hair plucks, 28–29, 44,50–52
hand washing, 146–147
havanese, 434, 648, 738
head tilt, 544, 557
Heartgardseeivermectin
hemangioma (HA), 574, 576, 577, 583
hemangiosarcoma (HSA), 574, 576, 577, 584
hemidesmosomes, 187–188
beta-hemolysin, 144
hemophagocytic syndrome, 384
hepatocutaneous syndromeseesuperficial necrolytic
dermatosis
herpes virus-associated dermatoses
canine, 713
feline,141,712,721–722
hidradenitis suppurativa, 161
high-dose dexamethasone suppression test
(HDDST), 399, 411
Himalayan cat
basal cell tumors, 673
facial dermatitis (dirty face syndrome), 62,
435
urticaria pigmentosa, 495
histiocytic proliferative disorders, 380–387
histiocytic sarcoma (malignant histiocytosis), 381
clinical features, 383,390–391, 392
diagnostics, 384, 385, 386
therapeutics, 387
histiocytoma
cutaneous, 380, 381
clinical features, 382,387–388
diagnostics, 384–385, 393
therapeutics, 386
malignant fibrous, 382, 383, 385, 387
histiocytosis
malignantseehistiocytic sarcoma
nasal planum, 67, 141
reactive cutaneous, 380
clinical features, 63,117,382,389–390
diagnostics, 385, 386, 393
therapeutics, 386
reactive systemic, 381
clinical features, 382–383,391–392
diagnostics, 385, 386
therapeutics, 386–387
histopathology
for cutaneous nonepitheliotropic lymphoma, 368
for deep mycoses, 524
for eosinophilic granuloma complex, 354
for epitheliotropic lymphoma, 368–369
for histiocytic proliferative disorders, 384–385
for hypothyroidism, 420
for leishmaniasis, 462, 466
for lupus erythematosus, 471
forMalasseziadermatitis, 483
for mycobacterial infections, 514
for panniculitis, 565–566, 573
for paraneoplastic dermatoses, 621, 622, 623
patterns, 41
for photodermatoses, 577
for preneoplastic dermatoses, 621, 622
report, 38, 38
for skin and adnexal tumors, 677–678
for superficial necrolytic dermatitis, 667
terminology,39–40
for viral dermatoses, 714–715
see alsobiopsy
hookworm migration, 64
hormone replacement therapy, human topicalsee
topical hormone replacement therapy, human
horn, cutaneous
actinic keratosis, 575, 618
canine papillomavirus infection,602,713, 724
Horner’s syndrome, 544, 557
hornet stings, 240–241, 243
horseflies (Tabanusspp.), 240
hot spotseeacute moist dermatitis
hovawart, 648
HuIFN-αseeinterferon-alpha
humectants, 438
husky, 65, 674
see alsoSiberian husky